Nicotine consumption is regulated by a human polymorphism in dopamine neurons

Area of Science:

• Neuroscience
• Genetics
• Pharmacology

Background:

• Smoking is a leading preventable cause of death globally.
• Genetic variations in the CHRNA3-CHRNA5-CHRNB4 gene cluster are linked to tobacco dependence and lung cancer risk.
• Nicotinic acetylcholine receptors (nAChRs) play a role in nicotine's effects.

Purpose of the Study:

• To investigate the role of the alpha5 nAChR subunit in dopaminergic neurons of the ventral tegmental area (VTA) in nicotine sensitivity and reinforcement.
• To determine if a specific human single-nucleotide polymorphism (rs16969968) in the alpha5 gene affects nicotine intake.

Main Methods:

• Used alpha5 knockout (α5(-/-)) mice in an intravenous nicotine self-administration task.
• Performed ex vivo and in vivo electrophysiological recordings to assess dopamine cell activation.
• Utilized lentiviral vectors for targeted re-expression of wild-type or mutant alpha5 subunits in the VTA and dopaminergic neurons.

Main Results:

• The alpha5 nAChR subunit in VTA dopaminergic neurons is crucial for regulating nicotine sensitivity and reinforcement.
• Alpha5 deficiency altered the minimum nicotine dose required for dopamine cell activation.
• The human variant rs16969968 demonstrated a partial loss of function, leading to increased nicotine consumption in mice.

Conclusions:

• Alpha5*-nAChRs in dopaminergic neurons are key regulators of nicotine intake.
• A specific human genetic variant linked to addiction risk impacts alpha5 nAChR function in vivo.
• This research establishes a link between a human genetic predisposition, its neuronal expression, and nicotine consumption patterns.